231 filings
Page 5 of 12
S-8
ibqtz78nla
11 Aug 20
Registration of securities for employees
4:26pm
8-K
eukqphan 44
11 Aug 20
Results of Operations and Financial Condition
7:01am
EFFECT
gq97 sedkxxn
16 Jun 20
Notice of effectiveness
12:15am
S-3/A
ea7dvop
11 Jun 20
Shelf registration (amended)
4:48pm
CORRESP
11k9s2wjxojomjhqd2
11 Jun 20
Correspondence with SEC
12:00am
8-K
4ujfqrty 9xms3y
10 Jun 20
Axovant Announces Year-End Financial Results and Expected Key Clinical Milestones in Q4 2020
6:02am
8-K
cnb3zf7zq ome
29 Apr 20
Entry into a Material Definitive Agreement
5:00pm
424B5
dn14u pw34mjg35
29 Apr 20
Prospectus supplement for primary offering
4:55pm
8-K
usqvz2w
24 Apr 20
Other Events
7:31am
8-K
c1vdx4xt q8qtvzez
20 Apr 20
Termination of a Material Definitive Agreement
5:21pm
8-K
sb7k1kigtp
26 Mar 20
Amendments to Articles of Incorporation or Bylaws
4:15pm
DEF 14C
z6d22rqq5jkjwiwe418
2 Mar 20
Information statement
6:03am
8-K
wlgg1295y6945vk
21 Feb 20
Other Events
5:16pm
424B5
0fwp ezsu
21 Feb 20
Prospectus supplement for primary offering
12:00am
424B5
ia7k2dgvcw7
19 Feb 20
Prospectus supplement for primary offering
5:28pm
PRE 14C
87bakk3oscy di8
19 Feb 20
Preliminary information
7:32am
8-K
lmn7g3
19 Feb 20
Departure of Directors or Certain Officers
6:01am